Medtronic puts some skin in intraocular lens maker PowerVision Inc. to bring its series C funding round to $24 million.
Medtronic Inc. (NYSE:MDT) has signed on as an investor in a $24 million financing round for PowerVision Inc.
The Belmont, Calif.-based PowerVision develops intraocular lenses with a novel technology that uses fluid inside the lens that allows natural forces in the eye to change the lens' shape and provide better focusing ability.
Other investors in the C round include Venrock, Advanced Technology Ventures, Frazier Healthcare Ventures and Panorama Capital.
"PowerVision believes its technology has the potential to create an average of 5 or more diopters of power change, equivalent to the accommodative range of a 35 year old, creating true independence from spectacles or other corrective lenses in patients who receive its implant. PowerVision's products are not yet approved or cleared for sale," company officials said in a release.
Medtronic is an investor in another Advanced Technology Ventures portfolio company, GI Dynamics of Lexington, Mass. MDT put $15 million in the company back in January 2010.
Terms of the investment were not announced, but Medtronic has made a practice of placing side bets on potentially disruptive technologies. The company has about $300 million spread around in emerging technologies, according to former CEO Bill Hawkins.
Hawkins told MassDevice that Fridley, Minn.-based Medtronic is always looking for new technologies it may have a strategic interest in.
St. Jude Medical calls another halt to its Nanostim clinical trial in Europe after serious adverse...
Sorin's shareholders approve the Italian medical device firm's merger with U.S.-based Cyberonics.
A trio of medical device companies - Evolent Health, EndoChoice and Corindus Vascular Robotics -...
Intrinsic Therapeutics' founder George Lambrecht starts Coravin, a high-tech wine device company that...